Novartis Investigative Site

Toronto, Ontario

Use our guide to learn which trials are right for you!

We've found
6 trials
at this facility
Sickle Cell Anemia Clinical Trial
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials
Advanced Malignancies Clinical Trial
Safety and Efficacy of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials
Diffuse Large B-Cell Lymphoma Clinical Trial
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials
Advanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12C NSCLC,CRC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,RAS/RAF Wild-type Other Solid Tumor Clinical Trial
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials
Advanced Hepatocellular Carcinoma Clinical Trial
Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials
Oncology Clinical Trial
Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations
Status: Enrolling, Phase I
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Toronto,
Click here to add this to my saved trials